跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
赛菲因 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Fitusiran Sodium Injection
Approved
化学药品
Fitusiran Sodium Injection
GENZYME CORPORATION
🇨🇳 National Medical Products Administration
Approval Date
Dec 9, 2025
Approval ID
8pdZR3iFl3I
Company
GENZYME CORPORATION
Type
化学药品
Approval Details
Approval Id
8pdZR3iFl3I
Approval Number
国药准字HJ20250145
Generic Name
芬妥司兰钠注射液
Generic Name En
Fitusiran Sodium Injection
Trade Name
赛菲因
Drug Type
化学药品
Dosage Form
注射剂
Strength
0.5ml: 50mg(预充式注射笔)
Reg Date
2025-12-09
Expired Date
2030-12-08
Company Name
GENZYME CORPORATION
Production Company Name
Vetter Pharma-Fertigung GmbH & Co. KG
Company Detail Path
/organization/genzyme-corporation
Production Company Detail Path
/organization/vetter-pharma-fertigung-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 9, 2025
Approval ID
8pdZR3iFl3I
Type
化学药品
Back to NMPA Approvals